These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19276358)

  • 1. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes.
    Long CM; van Laarhoven HW; Bulte JW; Levitsky HI
    Cancer Res; 2009 Apr; 69(7):3180-7. PubMed ID: 19276358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging.
    Kadayakkara DK; Korrer MJ; Bulte JW; Levitsky HI
    Cancer Res; 2015 Jan; 75(1):51-61. PubMed ID: 25388285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of in vivo function of superparamagnetic iron oxide labelled murine dendritic cells during anti-tumour vaccination.
    Tavaré R; Sagoo P; Varama G; Tanriver Y; Warely A; Diebold SS; Southworth R; Schaeffter T; Lechler RI; Razavi R; Lombardi G; Mullen GE
    PLoS One; 2011; 6(5):e19662. PubMed ID: 21637760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide.
    Mou Y; Hou Y; Chen B; Hua Z; Zhang Y; Xie H; Xia G; Wang Z; Huang X; Han W; Ni Y; Hu Q
    Int J Nanomedicine; 2011; 6():2633-40. PubMed ID: 22114494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine.
    Pizzurro GA; Tapia IJ; Sganga L; Podhajcer OL; Mordoh J; Barrio MM
    Cancer Immunol Immunother; 2015 Nov; 64(11):1393-406. PubMed ID: 26197849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo MRI Tracking of Tumor Vaccination and Antigen Presentation by Dendritic Cells.
    Bulte JWM; Shakeri-Zadeh A
    Mol Imaging Biol; 2022 Apr; 24(2):198-207. PubMed ID: 34581954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes.
    de Chickera S; Willert C; Mallet C; Foley R; Foster P; Dekaban GA
    Int Immunol; 2012 Jan; 24(1):29-41. PubMed ID: 22190576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
    Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI.
    Brewer KD; Lake K; Pelot N; Stanford MM; DeBay DR; Penwell A; Weir GM; Karkada M; Mansour M; Bowen CV
    Vaccine; 2014 Dec; 32(51):6956-6962. PubMed ID: 25444822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imiquimod combined with dendritic cell vaccine decreases Treg proportion and enhances anti-tumor responses in mice bearing melanoma.
    Ren S; Wang Q; Zhang Y; Lu C; Li P; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Feb; 33(2):145-50. PubMed ID: 29762000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod enhances the potency of an exogenous BM-DC based vaccine against mouse melanoma.
    Ren S; Wang Q; Zhang Y; Song Y; Dong X; Zhang W; Qin X; Liu M; Yu T
    Int Immunopharmacol; 2018 Nov; 64():69-77. PubMed ID: 30149266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using magnetic resonance imaging to evaluate dendritic cell-based vaccination.
    Ferguson PM; Slocombe A; Tilley RD; Hermans IF
    PLoS One; 2013; 8(5):e65318. PubMed ID: 23734246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-experienced CD4(+) T cells limit naïve T-cell priming in response to therapeutic vaccination in vivo.
    Schiering C; Guarnerio J; Basso V; Muzio L; Mondino A
    Cancer Res; 2010 Aug; 70(15):6161-70. PubMed ID: 20631073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor ablation plus co-administration of CpG and saponin adjuvants affects IL-1 production and multifunctional T cell numbers in tumor draining lymph nodes.
    Raaijmakers TK; van den Bijgaart RJE; den Brok MH; Wassink M; de Graaf A; Wagenaars JA; Nierkens S; Ansems M; Scheffer GJ; Adema GJ
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model.
    Zhang Z; Li W; Procissi D; Li K; Sheu AY; Gordon AC; Guo Y; Khazaie K; Huan Y; Han G; Larson AC
    Radiology; 2015 Jan; 274(1):192-200. PubMed ID: 25222066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.